# Effect of Entacapone on Bodyweight Loss in Obese Population

> **NCT02349243** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Kaichun Wu** · enrollment: 30 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Entacapone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02349243
- **Lead sponsor:** Kaichun Wu
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2015-09
- **Final completion:** 2015-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349243, "Effect of Entacapone on Bodyweight Loss in Obese Population". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02349243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*